Congratulations to Doctor Camille Cohen, who has been awarded a Nephro-transplantation project grant from the SFNDT – Société Francophone de Néphrologie, Dialyse et Transplantation (French-speaking Society of Nephrology, Dialysis and Transplantation).
Nephrologist, researcher and head of the “Renal diseases and monoclonal immunoglobulins” team at CRI – Inflammation Research CenterDr Camille Cohen is also co-coordinator of FHU INFIRE.
What is the aim of the award-winning project?
The InProgCKD project aims to decipher the early signals of inflammation in the kidney and the interactions between kidney cells that contribute to the development of renal fibrosis, a key step in the worsening of chronic kidney disease (CKD).
Why is this important?
CKD affects 1 in 10 people worldwide and could become the 5ᵉ cause of death by 2040.
By combining molecular and histopathological analyses with clinical biopsy data, InProgCKD seeks to identify new predictive markers of progression and possible innovative therapeutic targets.
This work could pave the way for novel approaches to preventing irreversible degradation of kidney function, both in transplantation and in chronic kidney disease.
Congratulations again to Camille Cohen for this award and for her promising contribution to research in nephrology, dialysis and transplantation!
Photo credits: SFNDT – Société Francophone de Néphrologie, Dialyse et Transplantation and Mickaël Bobot
